Major depression symptom severity associations with willingness to exert effort and patch foraging strategy.

Laura A Bustamante, Deanna M Barch, Johanne Solis, Temitope Oshinowo, Ivan Grahek, Anna B Konova, Nathaniel D Daw, Jonathan D Cohen
Author Information
  1. Laura A Bustamante: Princeton Neuroscience Institute, Princeton University, Princeton, NJ, USA. ORCID
  2. Deanna M Barch: Department of Psychological & Brain Science and Psychiatry, Washington University in St. Louis, St. Louis, MO, USA. ORCID
  3. Johanne Solis: Department of Psychiatry, Rutgers University, New Brunswick, NJ, USA. ORCID
  4. Temitope Oshinowo: Princeton Neuroscience Institute and Department of Molecular Biology, Princeton University, Princeton, NJ, USA. ORCID
  5. Ivan Grahek: Department of Cognitive and Psychological Sciences, Brown University, Providence, RI, USA. ORCID
  6. Anna B Konova: Department of Psychiatry, Rutgers University, New Brunswick, NJ, USA. ORCID
  7. Nathaniel D Daw: Princeton Neuroscience Institute and Department of Psychology, Princeton University, Princeton, NJ, USA. ORCID
  8. Jonathan D Cohen: Princeton Neuroscience Institute and Department of Psychology, Princeton University, Princeton, NJ, USA. ORCID

Abstract

BACKGROUND: Individuals with major depressive disorder (MDD) can experience reduced motivation and cognitive function, leading to challenges with goal-directed behavior. When selecting goals, people maximize 'expected value' by selecting actions that maximize potential reward while minimizing associated costs, including effort 'costs' and the opportunity cost of time. In MDD, differential weighing of costs and benefits are theorized mechanisms underlying changes in goal-directed cognition and may contribute to symptom heterogeneity.
METHODS: We used the Effort Foraging Task to quantify cognitive and physical effort costs, and patch leaving thresholds in low effort conditions (reflecting perceived opportunity cost of time) and investigated their shared versus distinct relationships to clinical features in participants with MDD ( = 52, 43 in-episode) and comparisons ( = 27).
RESULTS: Contrary to our predictions, none of the decision-making measures differed with MDD diagnosis. However, each of the measures was related to symptom severity, over and above effects of ability (i.e. performance). Greater anxiety symptoms were selectively associated with cognitive effort cost (i.e. greater willingness to exert effort). Anhedonia and behavioral apathy were associated with increased physical effort costs. Finally, greater overall depression was related to decreased patch leaving thresholds.
CONCLUSIONS: Markers of effort-based decision-making may inform understanding of MDD heterogeneity. Increased willingness to exert cognitive effort may contribute to anxiety symptoms such as worry. Decreased leaving threshold associations with symptom severity are consistent with reward rate-based accounts of reduced vigor in MDD. Future research should address subtypes of depression with or without anxiety, which may relate differentially to cognitive effort decisions.

Keywords

References

  1. Psychiatry Res. 2006 Nov 29;145(1):39-48 [PMID: 17045658]
  2. Int Clin Psychopharmacol. 2010 Nov;25(6):328-33 [PMID: 20805756]
  3. Biol Psychiatry. 2020 Jul 1;88(1):83-94 [PMID: 32171465]
  4. Proc Natl Acad Sci U S A. 2023 Dec 12;120(50):e2221510120 [PMID: 38064507]
  5. J Affect Disord. 2016 May 15;196:97-100 [PMID: 26919058]
  6. J Affect Disord. 2021 Mar 15;283:254-261 [PMID: 33571794]
  7. Psychol Med. 2014 Jul;44(10):2029-40 [PMID: 24168753]
  8. Arch Intern Med. 2006 May 22;166(10):1092-7 [PMID: 16717171]
  9. J Abnorm Psychol. 2012 Feb;121(1):51-60 [PMID: 21842963]
  10. Annu Rev Neurosci. 2017 Jul 25;40:99-124 [PMID: 28375769]
  11. Annu Rev Neurosci. 2015 Jul 8;38:1-23 [PMID: 25705929]
  12. Elife. 2020 Dec 22;9: [PMID: 33350387]
  13. Brain. 2018 Mar 1;141(3):629-650 [PMID: 29194534]
  14. PLoS One. 2017 Jan 11;12(1):e0169938 [PMID: 28076387]
  15. Neuron. 2013 Jul 24;79(2):217-40 [PMID: 23889930]
  16. Ann N Y Acad Sci. 2007 May;1104:340-56 [PMID: 17360802]
  17. Schizophr Bull Open. 2021 Jun 11;2(1):sgab022 [PMID: 34901865]
  18. PLoS Comput Biol. 2012;8(10):e1002716 [PMID: 23055916]
  19. Front Psychiatry. 2021 Nov 04;12:747139 [PMID: 34803766]
  20. Curr Opin Behav Sci. 2018 Aug;22:128-135 [PMID: 29503842]
  21. Psychol Med. 2024 Dec 02;:1-12 [PMID: 39618329]
  22. Psychol Med. 2023 Apr;53(5):1850-1859 [PMID: 37310334]
  23. Nat Rev Drug Discov. 2012 Feb 01;11(2):141-68 [PMID: 22293568]
  24. Am J Psychiatry. 2004 Dec;161(12):2163-77 [PMID: 15569884]
  25. Biol Psychiatry Cogn Neurosci Neuroimaging. 2022 Nov;7(11):1158-1169 [PMID: 35952972]
  26. Elife. 2016 Mar 01;5: [PMID: 26928075]
  27. Neurosci Biobehav Rev. 2019 Jul;102:371-381 [PMID: 31047891]
  28. J Psychiatr Res. 1993 Jul-Sep;27(3):259-73 [PMID: 8295158]
  29. Biol Psychiatry. 2023 Sep 15;94(6):501-510 [PMID: 37080416]
  30. J Neurol Neurosurg Psychiatry. 1960 Feb;23:56-62 [PMID: 14399272]
  31. J Pers Assess. 1984 Jun;48(3):306-7 [PMID: 16367530]
  32. PLoS One. 2009 Aug 12;4(8):e6598 [PMID: 19672310]
  33. Psychother Psychosom. 2009;78(2):91-7 [PMID: 19218827]
  34. Psychol Med. 2017 Feb;47(3):426-437 [PMID: 27786144]
  35. PLoS One. 2011;6(8):e23178 [PMID: 21853083]
  36. Psych J. 2020 Apr;9(2):210-222 [PMID: 31692266]
  37. Cogn Affect Behav Neurosci. 2015 Dec;15(4):837-53 [PMID: 25917000]
  38. JAMA Psychiatry. 2020 May 1;77(5):513-522 [PMID: 32074255]
  39. Br J Psychiatry Suppl. 1996 Jun;(30):17-30 [PMID: 8864145]
  40. Evid Based Ment Health. 2016 Nov;19(4):e23 [PMID: 27686427]
  41. Psychopharmacology (Berl). 2007 Apr;191(3):507-20 [PMID: 17031711]
  42. Sci Rep. 2019 Feb 8;9(1):1689 [PMID: 30737422]
  43. PLoS One. 2015 Apr 02;10(3):e0121945 [PMID: 25835001]
  44. Front Behav Neurosci. 2018 Mar 23;12:52 [PMID: 29628879]
  45. Psychol Med. 2023 Jul;53(9):4228-4235 [PMID: 35466895]
  46. J Behav Ther Exp Psychiatry. 2023 Dec;81:101888 [PMID: 37352732]
  47. Psychophysiology. 2012 Jun;49(6):842-52 [PMID: 22332819]
  48. Theor Popul Biol. 1976 Apr;9(2):129-36 [PMID: 1273796]
  49. Emotion. 2007 May;7(2):336-53 [PMID: 17516812]
  50. Psychiatry Res. 2014 Dec 30;220(3):874-82 [PMID: 25262638]
  51. J Neurosci. 2017 Jun 7;37(23):5681-5689 [PMID: 28483979]
  52. Nat Commun. 2023 Sep 30;14(1):6122 [PMID: 37777515]
  53. Eur Arch Psychiatry Clin Neurosci. 2022 Aug;272(5):859-871 [PMID: 35079855]
  54. J Gen Intern Med. 2001 Sep;16(9):606-13 [PMID: 11556941]
  55. Nat Rev Neurosci. 2018 Aug;19(8):470-484 [PMID: 29946157]
  56. J Abnorm Psychol. 2012 Aug;121(3):553-8 [PMID: 22775583]
  57. Int J Neuropsychopharmacol. 2015 Jul 25;19(2): [PMID: 26209859]
  58. Biol Psychiatry Cogn Neurosci Neuroimaging. 2023 Jul;8(7):687-694 [PMID: 35948258]
  59. Psychol Bull. 2013 Jan;139(1):81-132 [PMID: 22642228]
  60. Neuroimage. 2000 May;11(5 Pt 1):424-46 [PMID: 10806029]

Grants

  1. T32 MH065214/NIMH NIH HHS
  2. T32MH065214/NIMH NIH HHS

Word Cloud

Created with Highcharts 10.0.0effortMDDcognitivecostsmaysymptomanxietyassociatedcostphysicalpatchleavingdecision-makingseveritywillingnessexertdepressionmajordepressivedisorderreducedgoal-directedselectingmaximizerewardopportunitytimecontributeheterogeneitythresholds=measuresrelatediesymptomsgreatereffort-basedassociationsforagingBACKGROUND:Individualscanexperiencemotivationfunctionleadingchallengesbehaviorgoalspeople'expectedvalue'actionspotentialminimizingincluding'costs'differentialweighingbenefitstheorizedmechanismsunderlyingchangescognitionMETHODS:usedEffortForagingTaskquantifylowconditionsreflectingperceivedinvestigatedsharedversusdistinctrelationshipsclinicalfeaturesparticipants5243in-episodecomparisons27RESULTS:ContrarypredictionsnonediffereddiagnosisHowevereffectsabilityperformanceGreaterselectivelyAnhedoniabehavioralapathyincreasedFinallyoveralldecreasedCONCLUSIONS:MarkersinformunderstandingIncreasedworryDecreasedthresholdconsistentrate-basedaccountsvigorFutureresearchaddresssubtypeswithoutrelatedifferentiallydecisionsMajorstrategycontrolcomputationalpsychiatry

Similar Articles

Cited By